Ju Li
Impact in
Papers in
-
- Lymphoma Diagnosis and Treatment 9
- Spine and Intervertebral Disc Pathology 3
-
- CRISPR and Genetic Engineering 14
- Muscle Physiology and Disorders 8
- Co-authors
- Remo Panaccione (3 shared papers)William J. Sandborn (3 shared papers)Jean-Frederic Colombel (3 shared papers)Paul F. Pollack (2 shared papers)Jeffrey D. Kent (2 shared papers)Paul J. Rutgeerts (2 shared papers)Robert Allan Enns (1 shared paper)Stefan Schreiber (1 shared paper)
- Journals
- Nature Communications (5 papers)Medical Physics (3 papers)ACS Synthetic Biology (3 papers)Journal of Animal Science (3 papers)Journal of Inflammation Research (2 papers)
- Partner nations
- ChinaUnited StatesFrance
In The Last Decade
Ju Li
79 papers receiving 4.9k citations
Ju Li's Hit Papers
Peers
Comparison fields: 5 of 101
- Genetics 2.3k
- Aging 36
- Pathology and Forensic Medicine 310
- Molecular Biology 866
- Animal Science and Zoology 91
Countries citing papers authored by Ju Li
This map shows the geographic impact of Ju Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ju Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ju Li more than expected).
Fields of papers citing papers by Ju Li
This network shows the impact of papers produced by Ju Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ju Li. The network helps show where Ju Li may publish in the future.
Co-authors
The 25 scholars most cited alongside Ju Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 81 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Adalimumab for Maintenance of Clinical Response and Remission in Patients With Crohn’s Disease: The CHARM Trial Hit paper breakdown → | 2006 | 1847 |
| 2 | Adalimumab Induction Therapy for Crohn Disease Previously Treated with Infliximab Hit paper breakdown → | 2007 | 809 |
| 3 | Glycosylase base editors enable C-to-A and C-to-G base changes Hit paper breakdown → | 2020 | 391 |
| 4 | 2014 | 329 | |
| 5 | 2021 | 148 | |
| 6 | 2006 | 123 | |
| 7 | 2013 | 114 | |
| 8 | 2009 | 111 | |
| 9 | 2017 | 88 | |
| 10 | 2021 | 62 | |
| 11 | 2024 | 57 | |
| 12 | 2002 | 47 | |
| 13 | 2014 | 45 | |
| 14 | 2023 | 42 | |
| 15 | 2011 | 39 | |
| 16 | 2018 | 38 | |
| 17 | 2011 | 37 | |
| 18 | 2009 | 35 | |
| 19 | 2019 | 35 | |
| 20 | 2013 | 33 |
About Ju Li
Ju Li is a scholar working on Pathology and Forensic Medicine, Molecular Biology, Radiation, Signal Processing and Animal Science and Zoology, having authored 81 papers that have together received 5.0k indexed citations. Recurring topics across this work include CRISPR and Genetic Engineering (14 papers), Lymphoma Diagnosis and Treatment (9 papers), Muscle Physiology and Disorders (8 papers), Advanced Radiotherapy Techniques (3 papers), Spine and Intervertebral Disc Pathology (3 papers), Inflammatory Bowel Disease (3 papers), T-cell and B-cell Immunology (2 papers) and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (2 papers). The work is most often cited by research in Genetics (2.3k citations), Aging (36 citations), Pathology and Forensic Medicine (310 citations), Molecular Biology (866 citations) and Animal Science and Zoology (91 citations). Ju Li has collaborated with scholars based in China, United States and France. Frequent co-authors include Remo Panaccione, William J. Sandborn, Jean-Frederic Colombel, Paul F. Pollack, Jeffrey D. Kent, Paul J. Rutgeerts, Robert Allan Enns, Stefan Schreiber, Stephen B. Hanauer and Sally Johnson. Their work appears in journals such as Nature Communications, Medical Physics, ACS Synthetic Biology, Journal of Animal Science and Journal of Inflammation Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.